Search Results
Targeted TKIs Used for Treatment of ALK-Positive NSCLC
What targeted therapies are used for people with the ALK mutation?
2023 Best of Lung: Targeted Therapies in Lung Cancer
Treating NSCLC Patients With a Next-Generation ALK TKI
ALK Positive Lung Cancer in 2023 and Beyond: Thinking Outside the Box with Dr. Alice Shaw
Alecensa: Targeted Therapy for ALK-Positive Lung Cancer
Emerging ALK/ROS1 TKIs for NSCLC
Macrocyclic TKIs in Treatment-Naïve and Pretreated Fusion-Positive NSCLC and Other Tumors
Third-Line TKI Therapy in ALK+ NSCLC
Frontline Targeted Therapy in ALK+ NSCLC
First and Second Generation ALK Inhibitors for the Treatment of Lung Cancer
ALK TKI Side Effects and Acquired Resistance - 2022 Program: Targeted Therapies Forum
